Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $48.8700 (1.45%) ($48.8700 - $48.8700) on Fri. Feb. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.98% (three month average) | RSI | 57 | Latest Price | $48.8700(1.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.4% a day on average for past five trading days. | Weekly Trend | HALO advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(51%) IWM(49%) IWC(46%) ARKG(44%) | Factors Impacting HALO price | HALO will decline at least -1.49% in a week (0% probabilities). VIXM(-32%) VXX(-13%) UUP(-13%) TBT(-1%) TLT(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.49% (StdDev 2.98%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $48.33(1.12%) | 10 Day Moving Average | $48.2(1.39%) | 20 Day Moving Average | $47.3(3.32%) | To recent high | -1.2% | To recent low | 48.5% | Market Cap | $6.679b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |